The companies will help expand the Momentive panel, which currently covers more than 144 million respondents, to ‘several million’ more people for the purposes of B2B research.

The panel will give Momentive customers access to more granular targeting criteria for B2B audiences.

The panel will allow studies and recurring research like brand tracking in multiple sectors including technology, healthcare, IT and financial, and also includes specialised targeting and data consistency.

Professions that can now be targeted using Momentive panel include IT directors at software companies, technicians in the biotech industry, and patients across all therapeutic areas, including rare diseases.

Michael Sanfelippo, senior vice-president of customer experience at Dynata, said: “We know from working with our clients that true insights come from real people, vetted and verified, that fit the purpose of a research project.

“Those panellists – from C-level to operational and clinical leaders – are qualified using proprietary automated and manual processes to ensure they are real, qualified and responsive.”